Clinical Trials in Brookline, Massachusetts
14 recruiting
Showing 1–14 of 14 trials
Recruiting
Phase 3
A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
Phelan-McDermid Syndrome
Neuren Pharmaceuticals Limited160 enrolled5 locationsNCT07281079
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Arthritis, Psoriatic
Janssen Research & Development, LLC750 enrolled214 locationsNCT06807424
Recruiting
Phase 2
A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure
Lyme Disease
Tarsus Pharmaceuticals, Inc.700 enrolled19 locationsNCT07562087
Recruiting
Not Applicable
Piloting the Competence in Romance and Understanding Sexual Health Curriculum
AutismAutism Spectrum DisorderAutism Disorder
Boston Children's Hospital40 enrolled1 locationNCT07406100
Recruiting
Not Applicable
Biomarkers Research in Anxiety for Validation and Efficacy
AutismAutism Spectrum Disorder
Boston Children's Hospital25 enrolled1 locationNCT06221176
Recruiting
Phase 3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
AstraZeneca15,100 enrolled1264 locationsNCT07000357
Recruiting
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
Pain
Boston Scientific Corporation4,800 enrolled118 locationsNCT01719055
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Schizophrenia
Bristol-Myers Squibb166 enrolled44 locationsNCT07288567
Recruiting
Phase 3
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
SchizophreniaAutism-Related Irritability
Karuna Therapeutics, Inc., a Bristol Myers Squibb company400 enrolled55 locationsNCT07424404
Recruiting
Phase 4
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
ModernaTX, Inc.30,000 enrolled150 locationsNCT07266558
Recruiting
Phase 4
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis
Multiple Sclerosis
Novartis Pharmaceuticals20 enrolled22 locationsNCT06444113
Recruiting
Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
COVID-19
BioNTech SE25,500 enrolled208 locationsNCT07300839
Recruiting
Phase 1
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Advanced Solid TumorNon-small Cell Lung CancerSolid Tumor+3 more
Bristol-Myers Squibb336 enrolled25 locationsNCT05245500
Recruiting
Neurophysiologic Biomarkers in Rett Syndrome
Rett SyndromeRTTRett Syndrome, Atypical
Children's Hospital of Philadelphia202 enrolled6 locationsNCT05932589